We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+19.36%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$561M
(+45%)
Cap. Flow
+$409M
Cap. Flow
% of AUM
22.52%
Top 10 Holdings %
Top 10 Hldgs %
16.32%
Holding
823
New
371
Increased
67
Reduced
65
Closed
283
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$20.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$13.2M |
| 3 |
SIX
Six Flags Entertainment Corp.
SIX
|
+$9.3M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$7.94M |
| 5 |
Centene
CNC
|
+$7.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$29.9M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$12.2M |
| 3 |
Five Below
FIVE
|
+$6.65M |
| 4 |
Kohl's
KSS
|
+$6.63M |
| 5 |
BKS
Barnes & Noble
BKS
|
+$5.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.91% |
| 2 | Consumer Discretionary | 2.56% |
| 3 | Technology | 1.71% |
| 4 | Energy | 1.64% |
| 5 | Industrials | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
PUT
DELISTED
Celgene Corp
CELG
| $50.2M | 2.76% |
+531,600
| New | +$46.5M |
|
|
2
CALL
Bristol-Myers Squibb
BMY
$132B
| $47.6M | 2.62% |
+997,200
| New | +$49.7M |
|
3
CALL
Walt Disney
DIS
$167B
| $32.2M | 1.78% |
290,400
+240,400
| +481% | +$26.9M |
|
4
CALL
Boeing
BA
$175B
| $29.2M | 1.61% |
+76,600
| New | +$29.5M |
|
|
5
PUT
Tapestry
TPR
$30.8B
| $28.1M | 1.55% |
+864,000
| New | +$30.3M |
|
|
6
PUT
Bristol-Myers Squibb
BMY
$132B
| $23.8M | 1.31% |
+498,500
| New | +$24.8M |
|
7
PUT
Targa Resources
TRGP
$57.6B
| $22.9M | 1.26% |
552,100
+341,000
| +162% | +$14.3M |
|
8
CALL
Novavax
NVAX
$1.22B
| $22.3M | 1.23% |
+101,080
| New | +$3.19M |
|
|
WAGE
9
CALL
DELISTED
WageWorks, Inc.
WAGE
| $20.8M | 1.15% |
+550,500
| New | +$18M |
|
|
10
PUT
Boeing
BA
$175B
| $19.1M | 1.05% |
+50,000
| New | +$19.2M |
|
|
11
Tapestry
TPR
$30.8B
| $18.8M | 1.04% |
+580,000
| New | +$20.3M |
|
12
CALL
Ascendis Pharma A/S
ASND
$16.5B
| $18.1M | 1% |
+153,800
| New | +$13.5M |
|
13
CALL
Union Pacific
UNP
$172B
| $16.7M | 0.92% |
+100,000
| New | +$16.1M |
|
14
CALL
Zimmer Biomet
ZBH
$18.4B
| $16.6M | 0.92% |
+133,900
| New | +$15.2M |
|
15
CALL
Papa John's
PZZA
$995M
| $15.5M | 0.86% |
293,200
+74,100
| +34% | +$3.27M |
|
|
16
CALL
Centene
CNC
$30.1B
| $14.3M | 0.79% |
+270,000
| New | +$16.4M |
|
|
CELG
17
CALL
DELISTED
Celgene Corp
CELG
| $14.1M | 0.78% |
+149,100
| New | +$13M |
|
|
MDCO
18
PUT
DELISTED
Medicines Co
MDCO
| $13.8M | 0.76% |
+494,900
| New | +$11.7M |
|
|
EXAS
19
PUT
DELISTED
Exact Sciences
EXAS
| $13.8M | 0.76% |
158,800
-198,800
| -56% | -$16.9M |
|
20
PUT
PG&E
PCG
$39.2B
| $13.5M | 0.74% |
758,500
+678,500
| +848% | +$11M |
|
21
PUT
Burlington
BURL
$23.4B
| $13.3M | 0.73% |
+85,000
| New | +$13.7M |
|
|
22
Bristol-Myers Squibb
BMY
$132B
| $13.1M | 0.72% |
275,000
+265,500
| +2,795% | +$13.2M |
|
23
CALL
Madrigal Pharmaceuticals
MDGL
$11.4B
| $12.6M | 0.7% |
100,800
| – | – |
|
24
PUT
Edwards Lifesciences
EW
$50B
| $12.6M | 0.69% |
+197,100
| New | +$11.2M |
|
|
ONCE
25
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $12.5M | 0.69% |
+110,000
| New | +$8.08M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q1 2019 Portfolio in Review
As of Q1 2019, Caption Management held 823 positions worth $1.81B, up 45% from $1.25B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $409M of net new capital in Q1 2019, opening 371 new positions and adding to 67 existing holdings. Its largest new stake was Tapestry: 580,000 shares worth $18.8M.
By sector, the portfolio is most concentrated in Healthcare at 3.9% of assets, down from 4.5% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Somnigroup International, an estimated $4.33M trimmed.
- Caption Management's largest Q1 2019 buy was Tapestry: 580,000 shares worth $18.8M.
- Caption Management added most to Bristol-Myers Squibb in Q1 2019, an estimated $13.2M increase.
- Caption Management's biggest Q1 2019 reduction was Somnigroup International, cutting an estimated $4.33M.
- Caption Management fully exited Caesars Entertainment in Q1 2019, selling an estimated $29.9M.
- Caption Management's ten largest holdings make up 16% of its $1.81B portfolio in Q1 2019.
- Caption Management opened 371 new positions and closed 283 in Q1 2019.
- Caption Management's portfolio value rose 45% quarter-over-quarter to $1.81B.
Based on Caption Management's 13F filing for Q1 2019, filed 14 May 2019.